Chlorinated lipid modification of proteins: Biomarkers of chlorine gas exposure
蛋白质的氯化脂质修饰:氯气暴露的生物标志物
基本信息
- 批准号:10160912
- 负责人:
- 金额:$ 18.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccidentsAcidsAddressAlabamaAldehydesAmino Acid MotifsAmino AcidsAntibodiesBiological AssayBiological MarkersCaringChemical WarfareChemical Warfare AgentsChemicalsChemistryChlorineDependenceDetectionDiagnostic Reagent KitsDoseElectronsEmploymentEndothelial CellsEpithelial CellsExposure toFutureGasesGlutathioneHumanHypochlorous AcidInhalationInvestigationLeadLettersLipidsLungMaintenanceModificationMusOutcomeOxidantsPharmacologic SubstancePhospholipidsPlasmaPlasmalogensPost-Translational Protein ProcessingProductionProteinsPublic HealthResearch PersonnelStructureSwimming PoolsTherapeuticTissue BanksTrainingTransportationWateradductairway epitheliumanalogantibody detectionchlorine gascohortdetection assaydiagnostic biomarkerexposed human populationimprovedimproved outcomeinstrumentliquid chromatography mass spectrometrymanufacturing processnew therapeutic targetnoveloutcome predictionoxidationprotein biomarkersrapid detectionsignature moleculesynthetic peptidetherapeutic targetwater treatment
项目摘要
Exposure to chlorine gas (Cl2) presents a significant threat to public health. Chlorine is a leading chemical
produced by volume in the US. Exposure to Cl2 has occurred as a result of train derailments, accidental
misuse by swimming pool maintenance workers, accidents at water treatment facilities, and chemical warfare.
Intentional exposure is a major concern since Cl2 is both a chemical warfare agent and potential chemical
terror agent. Diagnostic biomarkers are needed to determine the extent of Cl2 exposure to humans and to
predict outcomes, which ultimately could lead to improved therapeutic support and countermeasures. The Ford
lab discovered that both Cl2 and HOCl target host plasmalogen lipids, resulting in 2-chlorofatty aldehyde (2-CLFALD) and 2-chlorofatty acid (2-CLFA) production. These chlorinated lipids accumulate to robust levels in
lung and plasma of mice exposed to sub-lethal amounts of chlorine gas. In recent unpublished studies we have
shown plasma 2-CLFA levels are elevated 40-fold in a five-subject cohort of humans exposed to chlorine at a
water treatment facility near Birmingham, Alabama. Taken together, we have shown chlorinated lipids derived
from plasmalogen oxidation are currently the best biomarkers of Cl2 exposure to humans and have the
potential to be used to predict future outcomes that could lead to improved care following exposure.!Plasma
chlorinated lipids are quantified using LC/MS detection employing a triple quadrupole instrument. The
dependence on LC/MS detection is a limitation in implementing field analyses of Cl2 exposure using these
biomarkers. The proposed studies will address this problem by identifying chlorolipid-modified proteins
produced following Cl2 exposure. Future studies producing antibodies to chlorolipid-modified proteins could
then be used to develop diagnostic kits. It is proposed that chlorinated lipids covalently modify proteins.
The identification of specific proteins and amino acid residues modified by chlorinated lipids will be used in
future studies to develop antibodies that can be used for rapid detection assays. Additionally, it is envisioned
that identifying chlorinated lipid-modified proteins as a result of Cl2 exposure may provide new targets for future
investigations to develop countermeasures to Cl2 exposure. There are three specific aims.
Specific Aim 1 will identify amino acid motifs and proteins modified by 2-CLFALD.
Specific Aim 2 will identify amino acid motifs and proteins modified by 2-CLFA.
Specific Aim 3 will identify chlorinated lipid-modified proteins in lung and plasma from mice exposed to Cl2.
These studies will identify chlorinated lipid-modified proteins, and show that they are present in plasma of Cl2
exposed mice. Furthermore, these proposed R21 studies have the potential to lead to new investigations in the
future to develop improved countermeasures for, and improve outcomes of, Cl2 exposure.
接触氯气(CL2)对公共卫生构成了重大威胁。氯是领先的化学物质
由美国的数量产生。由于火车出轨,意外而发生的CL2暴露
游泳池维护人员滥用,水处理设施中的事故和化学战。
故意暴露是一个主要问题,因为CL2既是化学战剂,又是潜在的化学物质
恐怖分子。需要诊断生物标志物来确定CL2暴露于人类的程度和
预测结果,最终可能会改善治疗支持和对策。福特
LAB发现CL2和HOCL靶宿主血浆脂质脂质,导致2-氯氟醛(2-Clfald)和2-氯氟脂蛋白酸(2-CLFA)产生。这些氯化脂质在
暴露于亚致死量的氯气的小鼠的肺和血浆。在最近未发表的研究中,我们有
显示的血浆2-CLFA水平在暴露于氯的五个受试者队列中升高了40倍
阿拉巴马州伯明翰附近的水处理设施。总之,我们显示了衍生的氯化脂质
目前,从血浆原成因氧化是CL2暴露于人类的最佳生物标志物,并具有
潜力用于预测未来结果,这些结果可能会导致暴露后改善护理。
使用三倍四极杆仪器使用LC/MS检测对氯化脂质进行定量。这
对LC/MS检测的依赖是使用这些实施CL2暴露的现场分析的限制
生物标志物。拟议的研究将通过鉴定叶绿素改性蛋白来解决此问题
在CL2暴露后产生。未来产生抗叶绿素改性蛋白抗体的研究可能
然后用于开发诊断套件。建议氯化脂质共价修改蛋白质。
通过氯化脂质修饰的特定蛋白质和氨基酸残基的鉴定将用于
未来的研究开发可用于快速检测测定的抗体。另外,它设想
由于CL2暴露而识别氯化脂质改性蛋白可能会为将来提供新的目标
调查以发展与CL2暴露的对策。有三个特定的目标。
特定的目标1将鉴定由2-Clfald修饰的氨基酸基序和蛋白质。
特定的目标2将鉴定由2-CLFA修饰的氨基酸基序和蛋白质。
特定的目标3将鉴定肺中氯化脂质改性的蛋白质和暴露于CL2的小鼠的血浆。
这些研究将鉴定氯化脂质改性蛋白,并表明它们存在于Cl2的血浆中
裸露的小鼠。此外,这些拟议的R21研究有可能导致在
未来可以改善CL2暴露的对策并改善结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A. FORD其他文献
DAVID A. FORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A. FORD', 18)}}的其他基金
Halolipid-Neutrophil Extracellular Trap Axis in Halogen Lung Injury
卤素肺损伤中的氟脂-中性粒细胞胞外俘获轴
- 批准号:
10685387 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Halolipid-Neutrophil Extracellular Trap Axis in Halogen Lung Injury
卤素肺损伤中的氟脂-中性粒细胞胞外俘获轴
- 批准号:
10507044 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Chlorinated Lipids in Myocardial Ischemia/Reperfusion
氯化脂质在心肌缺血/再灌注中的作用
- 批准号:
8227162 - 财政年份:2012
- 资助金额:
$ 18.94万 - 项目类别:
Chlorinated Lipids in Myocardial Ischemia/Reperfusion
氯化脂质在心肌缺血/再灌注中的作用
- 批准号:
8403793 - 财政年份:2012
- 资助金额:
$ 18.94万 - 项目类别:
Serum chlorinated lipids as predictors of cardiovascular risk in lupus
血清氯化脂质作为狼疮心血管风险的预测因子
- 批准号:
7897511 - 财政年份:2010
- 资助金额:
$ 18.94万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深层碳酸盐岩酸蚀裂缝中反应-非线性两相流界面演化机制研究
- 批准号:52304047
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核苷酸代谢酶氧化修饰调控上皮干细胞命运在口腔白斑病光动力治疗复发中的机制与意义研究
- 批准号:82330029
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
RNF31通过厚壁菌代谢产物3-氧代胆碱酸调控RORγ信号轴抑制Th17细胞分化—溃疡性结肠炎干预新靶点
- 批准号:82360112
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Triterpenoids in mitigation of radiation induced acute or delayed inflammation
三萜类化合物可减轻辐射引起的急性或迟发性炎症
- 批准号:
10852214 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Project 4: Post-Exposure Biomarkers and Remediation of Radionuclide Contaminants
项目4:暴露后生物标志物和放射性核素污染物的修复
- 批准号:
10589887 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Project 4: Post-Exposure Biomarkers and Remediation of Radionuclide Contaminants
项目4:暴露后生物标志物和放射性核素污染物的修复
- 批准号:
10327399 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Acute Prenatal Alcohol Exposure Potentiates Conotruncal Defects in the Setting of a Permissive Genetic Background
在允许的遗传背景下,急性产前酒精暴露会加剧圆锥干缺陷
- 批准号:
10731366 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Comprehensive analysis of fitness effects and epistasis along a billion-year evolutionary trajectory
十亿年进化轨迹上的适应度效应和上位性综合分析
- 批准号:
10212033 - 财政年份:2021
- 资助金额:
$ 18.94万 - 项目类别: